Cargando…
Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council
Atopic dermatitis (AD) is a prevalent disease worldwide and is associated with systemic comorbidities representing a significant burden on patients, their families, and society. Therapeutic options for AD remain limited, in part because of a lack of well-characterized animal models. There has been i...
Autores principales: | Eyerich, Kilian, Brown, Sara J., Perez White, Bethany E., Tanaka, Reiko J., Bissonette, Robert, Dhar, Sandipan, Bieber, Thomas, Hijnen, Dirk J., Guttman-Yassky, Emma, Irvine, Alan, Thyssen, Jacob P., Vestergaard, Christian, Werfel, Thomas, Wollenberg, Andreas, Paller, Amy S., Reynolds, Nick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626639/ https://www.ncbi.nlm.nih.gov/pubmed/30414395 http://dx.doi.org/10.1016/j.jaci.2018.10.033 |
Ejemplares similares
-
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018) -
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019) -
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group
por: Alexander, H., et al.
Publicado: (2019) -
Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021) -
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019)